The Clinical Development Team at PreciseDx is responsible for designing and implementing clinical studies that assess the efficacy and safety of innovative cancer risk stratification techniques. This team collaborates with research and clinical partners to analyze morphology features, advance patient-specific risk information, and refine personalized treatment options, ultimately contributing to improved patient outcomes in oncology.
View all